Comparing the Long-term Outcomes of Coronary Artery Bypass Grafting (CABG) vs. Percutaneous Coronary Intervention (PCI) in Patients with Multivessel Disease- A Systematic Review and Meta-Analysis.
Rubela Ray, Shivam Singla, Ghazala S Virk, Sarah Hack, Zaghum Abbas, Hemamalini Anand Murugesan, Arhum Mahmood, Mahnoor Shah, Samra Khalid, Sana Afzal, Izzat Izzat
{"title":"Comparing the Long-term Outcomes of Coronary Artery Bypass Grafting (CABG) vs. Percutaneous Coronary Intervention (PCI) in Patients with Multivessel Disease- A Systematic Review and Meta-Analysis.","authors":"Rubela Ray, Shivam Singla, Ghazala S Virk, Sarah Hack, Zaghum Abbas, Hemamalini Anand Murugesan, Arhum Mahmood, Mahnoor Shah, Samra Khalid, Sana Afzal, Izzat Izzat","doi":"10.2174/011573403X402044251204104520","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) are standard treatments for Multivessel Coronary Artery Disease (MVD). Their long-term comparative effectiveness remains debated.</p><p><strong>Method: </strong>A systematic review and meta-analysis of randomized and observational studies was conducted, including patients with MVD followed for ≥5 years. Data were pooled using randomor fixed-effects models, depending on the level of heterogeneity.</p><p><strong>Results: </strong>Thirteen studies met the inclusion criteria. CABG was associated with reduced all-cause mortality (RR 0.82, 95% CI 0.72-0.91) and fewer repeat revascularizations (RR 1.98, 95% CI 1.74-2.26) compared with PCI. Stroke risk was slightly higher after CABG.</p><p><strong>Discussion: </strong>Findings suggest CABG provides superior survival and event reduction in long-term follow-up, particularly in higher-risk subgroups. However, the modestly increased stroke risk highlights the need for individualized decision-making, taking into account patient comorbidities, anatomy, and surgical suitability.</p><p><strong>Conclusion: </strong>CABG offers long-term survival and durability advantages over PCI in MVD, while PCI remains suitable for patients with lower-risk anatomy or when surgery is contraindicated.</p>","PeriodicalId":10832,"journal":{"name":"Current Cardiology Reviews","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13656238/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cardiology Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/011573403X402044251204104520","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Coronary Artery Bypass Grafting (CABG) and Percutaneous Coronary Intervention (PCI) are standard treatments for Multivessel Coronary Artery Disease (MVD). Their long-term comparative effectiveness remains debated.
Method: A systematic review and meta-analysis of randomized and observational studies was conducted, including patients with MVD followed for ≥5 years. Data were pooled using randomor fixed-effects models, depending on the level of heterogeneity.
Results: Thirteen studies met the inclusion criteria. CABG was associated with reduced all-cause mortality (RR 0.82, 95% CI 0.72-0.91) and fewer repeat revascularizations (RR 1.98, 95% CI 1.74-2.26) compared with PCI. Stroke risk was slightly higher after CABG.
Discussion: Findings suggest CABG provides superior survival and event reduction in long-term follow-up, particularly in higher-risk subgroups. However, the modestly increased stroke risk highlights the need for individualized decision-making, taking into account patient comorbidities, anatomy, and surgical suitability.
Conclusion: CABG offers long-term survival and durability advantages over PCI in MVD, while PCI remains suitable for patients with lower-risk anatomy or when surgery is contraindicated.
简介:冠状动脉旁路移植术(CABG)和经皮冠状动脉介入治疗(PCI)是多支冠状动脉疾病(MVD)的标准治疗方法。它们的长期相对有效性仍存在争议。方法:对随机和观察性研究进行系统回顾和荟萃分析,包括随访≥5年的MVD患者。根据异质性水平,使用随机或固定效应模型汇总数据。结果:13项研究符合纳入标准。与PCI相比,CABG降低了全因死亡率(RR 0.82, 95% CI 0.72-0.91),减少了重复血运重建术(RR 1.98, 95% CI 1.74-2.26)。冠脉搭桥后卒中风险略高。讨论:研究结果表明,CABG在长期随访中提供了更高的生存率和事件减少,特别是在高风险亚组中。然而,适度增加的中风风险强调了个性化决策的必要性,考虑到患者的合并症、解剖结构和手术适应性。结论:在MVD患者中,CABG比PCI具有长期生存和持久性优势,而PCI仍然适用于低风险解剖或手术禁忌的患者。
期刊介绍:
Current Cardiology Reviews publishes frontier reviews of high quality on all the latest advances on the practical and clinical approach to the diagnosis and treatment of cardiovascular disease. All relevant areas are covered by the journal including arrhythmia, congestive heart failure, cardiomyopathy, congenital heart disease, drugs, methodology, pacing, and preventive cardiology. The journal is essential reading for all researchers and clinicians in cardiology.